Veracyte (VCYT) Net Cash Flow (2012 - 2026)

Veracyte (VCYT) has 15 years of Net Cash Flow data on file, last reported at -$99.4 million in Q1 2026.

• Quarterly Net Cash Flow fell 87.71% year-over-year to -$99.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.4 million (up 443.35% YoY) and the FY2025 annual result came in at $122.9 million, up 417.92% from the prior year.
• Net Cash Flow fell to -$99.4 million in Q1 2026 per VCYT's latest filing, from $47.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $96.0 million in Q3 2025, with the low at -$99.4 million in Q1 2026.
• Average Net Cash Flow over 5 years is $5.4 million, with a median of $13.4 million recorded in 2023.
• Year-over-year, Net Cash Flow jumped 352.74% in 2023 and slumped 661.51% in 2025.
• Veracyte's Net Cash Flow stood at -$16.6 million in 2022, then jumped by 182.55% to $13.7 million in 2023, then slumped by 349.1% to -$34.1 million in 2024, then soared by 237.73% to $47.0 million in 2025, then slumped by 311.42% to -$99.4 million in 2026.
• Business Quant data shows VCYT's Net Cash Flow at -$99.4 million in Q1 2026, $47.0 million in Q4 2025, and $96.0 million in Q3 2025.